Fundraising Fox
Find your path to Stephen
Sign up to see every warm intro you have to Stephen
- Paths you didn't know you had: your email and LinkedIn already hold routes to Stephen. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
About
Stephen Rapecki originated the blockbuster biologic bimekizumab from discovery to approval, combining 30 years of hands-on drug discovery at Celltech/UCB with ongoing peer-reviewed immunology research and seed-stage cofounding and advising.
Invests in
BiotechDigital HealthHealthtechMedical Devices
Colleagues at Medicxi
Frequently asked questions
- Who is Stephen Rapecki?
- Stephen Rapecki originated the blockbuster biologic bimekizumab from discovery to approval, combining 30 years of hands-on drug discovery at Celltech/UCB with ongoing peer-reviewed immunology research and seed-stage cofounding and advising.
- Where does Stephen Rapecki work?
- Stephen Rapecki is Venture Partner at Medicxi.
- What does Stephen Rapecki invest in?
- Stephen Rapecki invests in Biotech, Digital Health, Healthtech, Medical Devices.
About this profile. Compiled from public sources — Medicxi's own website and public professional profiles — and summarised by Fundraising Fox; every fact is kept with where it came from. Spotted an error, or would rather not be listed? Email privacy@fundraisingfox.com · How we build profiles · Your rights